Evidence map›Paper›PMID 41071821›Full record

ArticlePLoS neglected tropical diseases2025

Leprosy stigma in the healthcare setting: Lived experiences of persons affected by leprosy in Niger.

Amina Paula Alio, Ibrahim Malam Mamane Sani, Yohanna Abdou, Moussa Gado, Issa Harouna, Bahadir Celiktemur

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amina Paula AlioUniversity of Rochester Medical Center, Rochester, New York, United States of America.ORCID 0000-0002-2171-5537
Ibrahim Malam Mamane SaniUniversité Abdou Moumouni, Niamey, Niger.
Yohanna AbdouThe Leprosy Mission, Niamey, Niger.
Moussa GadoProgramme Nationale de Lutte contre la Lèpre, Ministère de la Santé, Niamey, Niger.
Issa HarounaIDEA-Niger, Maradi, Niger.
Bahadir CeliktemurThe Leprosy Mission-Great Britain, London, United Kingdom.

Funding

Leprosy Research Initiative
6 · The paper itself

Abstract

Leprosy-related stigma is deeply rooted in history and permeates every aspect of society, and stigmatization by healthcare professionals is no exception. This paper explores the experiences of persons affected by leprosy with stigma in the healthcare setting throughout their treatment-seeking journey. We conducted one-on-one interviews with 112 individuals who experienced a leprosy diagnosis and underwent treatment. Data was collected in July and August 2022, in nine villages and one urban neighborhood in the region of Maradi, Niger. Over two-thirds of participants experienced some form of visible impairment due to leprosy. Throughout their treatment-seeking journey, healthcare providers were reported to have stigmatized patients by using hurtful language, isolating patients, physically distancing from patients, or refusing to treat. The extent of the stigmatization depended on, first, whether leprosy was recognized or not. Unfortunately, many healthcare providers did not detect the early signs of leprosy, therefore, patients were then not able to obtain treatment prior to physical impairment. Second, the level of stigmatization varied based on the degree and type of visible physical impairments (e.g., missing fingers or toes, limbs, blindness). These negative experiences with healthcare workers made treatment-seeking and adherence to treatment regimen less likely for patients. Our findings confirm the presence of leprosy stigma in the healthcare context in Niger. Increasing leprosy knowledge and addressing stigma among healthcare professionals is key to early diagnosis and treatment of leprosy.

Indexed as

LeprosySocial StigmaAdultAgedFemaleHealth PersonnelHumansMaleMiddle AgedNigerYoung Adult

Identifiers

PMID41071821
PMCPMC12527163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.